M. Moreau

发表

Secondary ion mass spectrometry as a tool for investigating radiopharmaceutical distribution at the cellular level: the example of I-BZA and (14)C-I-BZA.

E. Hindié, A. Veyre, N. Moins, 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Secondary Ion Mass Spectrometry as a Tool for Investigating Radiopharmaceutical Distribution at the Cellular Level: The Example of I-BZA and 14C-I-BZA

E. Hindié, A. Veyre, N. Moins, 2005 .

123I-N-(2-diethylaminoethyl)-2-iodobenzamide: a potential imaging agent for cutaneous melanoma staging

A. Veyre, N. Moins, J. Papon, 2002, European Journal of Nuclear Medicine and Molecular Imaging.

High resolution magic angle spinning NMR spectroscopy used to investigate the ability of drugs to bind to synthetic melanin.

N. Moins, J. Madelmont, M. Moreau, 2005, Pigment cell research.

Synthesis and evaluation of new iodine-125 radiopharmaceuticals as potential tracers for malignant melanoma.

J. Boire, A. Veyre, J. Papon, 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Melanin affinity of N-(2-diethylaminoethyl)-4-iodobenzamide, an effective melanoma imaging agent

A. Veyre, N. Moins, J. Papon, 2002, Melanoma research.

Labelled dyes, a new 125I-indomonocarbocyanine and 125I-BSP, in the exploration of experimental cholestasis and steatosis in the rat.

M. Moreau, F. Lapalus, G. Meyniel, 1981, British journal of experimental pathology.

Comparative physico-chemical properties, biological effects, and disposition in mice of four nitrogen mustards

J. Madelmont, M. Moreau, R. Plagne, 2004, Cancer Chemotherapy and Pharmacology.

Melanoma affinity in mice and immunosuppressed sheep of [(125)I]N-(4-dipropylaminobutyl)-4-iodobenzamide, a new targeting agent.

N. Moins, J. Papon, J. Madelmont, 2008, Nuclear medicine and biology.

Synthesis of a [99mTc] pharmacomodulated Cyclam—a potential radiotracer functional brain imaging

A. Veyre, J. Madelmont, M. Moreau, 1998 .

Synthesis, characterization and comparative biodistribution study of a new series of p-iodine-125 benzamides as potential melanoma imaging agents.

A. Veyre, N. Moins, J. Papon, 2001, Nuclear medicine and biology.

Phase II scintigraphic clinical trial of malignant melanoma and metastases with iodine-123-N-(2-diethylaminoethyl 4-iodobenzamide).

A. Veyre, J. Madelmont, P. Souteyrand, 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Evaluation in mice of some iodinated melanoma imaging agents using cryosectioning and multi-wire proportional counting

A. Veyre, N. Moins, J. Papon, 1999, European Journal of Nuclear Medicine.

Marquage par 14C du Chloro‐2 Ethyl Isocyanate. Application au Marquage de Chloroethyl Tetrazinone et de Chloroethylnitrosourees

A. Veyre, J. Madelmont, M. Moreau, 1988 .

Metabolism of a new radioprotector; S-acetyl-N-glycyl cysteamine. I. Absorption, distribution and excretion metabolites in mice bearing EMT6 tumours.

A. Veyre, J. Madelmont, J. Imbach, 1988, Xenobiotica; the fate of foreign compounds in biological systems.

A boronated benzamide as melanoma-seeking agent

N. Moins, J. Papon, M. Moreau, 1997 .

Marquage Par 14C Du[(Chloro‐2‐Ethyl)‐3 Nitroso‐3 Ureido]‐1′ Tri‐O‐Acetyl‐2′,3′,4′ α,β D‐Ribopyrannose Ou R.P.C.N.U.

J. Madelmont, M. Moreau, D. Godeneche, 1980 .

Synthesis, radiolabeling, and preliminary evaluation in mice of some (N-diethylaminoethyl)-4-iodobenzamide derivatives as melanoma imaging agents.

J. Boire, N. Moins, J. Papon, 1995, Nuclear medicine and biology.

Uptake in melanoma cells of N-(2-diethylaminoethyl)-2-iodobenzamide (BZA2), an imaging agent for melanoma staging: relation to pigmentation.

A. Veyre, N. Moins, J. Papon, 2005, Nuclear medicine and biology.

Disposition and metabolism in 1-(2-chloroethyl)-3-(2',3',4'-tri-o-acetyl, ribopyranosyl)-1-nitrosourea in rats.

J. Madelmont, M. Moreau, J. Duprat, 1982, Cancer research.

Technetium‐99m radiolabelling of an N‐amino‐alkyl‐benzamide nitrido‐ and oxo‐technetium bis(aminoethanethiol) derivative synthesis and biological results. Potential melanoma tracer agents

R. Pasqualini, J. Papon, M. Moreau, 1999 .

Synthesis and biodistribution of technetium-99m-labelled N-(diethylaminoethyl)benzamide via a bis(dithiocarbamate) nitridotechnetium(V) complex

A. Veyre, R. Pasqualini, J. Papon, 1999 .

Synthesis of three no-carrier-added O6-4-[125I] iodobenzylguanosine derivatives, new reagents for the assay of O6-alkylguanine-DNA alkyltransferase activity

A. Veyre, J. Madelmont, M. Moreau, 1995 .

Disposition of a new alkylating agent [14C]mitoclomine (N,N-bis(2'-chloroethyl)4-amino-2-methyl-1-methoxy-naphthalene).

J. Madelmont, M. Moreau, R. Plagne, 1978, Xenobiotica; the fate of foreign compounds in biological systems.

Synthese Et Marquage Au 14C Du N,N Dichloro‐2 Ethyl amino‐4 Methyl‐2 Methoxy‐1 Naphtalene Ou Mitoclomine

J. Madelmont, M. Moreau, D. Godeneche, 1978 .

Distribution of I-BZA (N-2-diethylaminoethyl-4-iodobenzamide) in grafted melanoma and normal skin: a study by secondary ion mass spectroscopy.

E. Hindié, A. Veyre, N. Moins, 2001, Cellular and molecular biology.

Metabolic disposition of 2-chloroethyl nitrosocarbamoylcystamine in rats.

J. Madelmont, M. Moreau, J. Duprat, 1985, Drug metabolism and disposition: the biological fate of chemicals.

Clinical study of [123I] N-(2-diethylaminoethyl)-4-iodobenzamide in the diagnosis of primary and metastatic ocular melanoma.

A. Veyre, M. Moreau, J. Bonafous, 1998, Acta ophthalmologica.

Synthesis, in vitro binding and biodistribution in B16 melanoma-bearing mice of new iodine-125 spermidine benzamide derivatives.

N. Moins, J. Papon, J. Madelmont, 2005, Nuclear medicine and biology.

Brain uptake of labelled adiphenine in rats.

A. Veyre, M. Moreau, P. Labarre, 1986, Biopharmaceutics & drug disposition.

Adiphenine plasma levels and blood-brain barrier crossing in the rat

A. Veyre, M. Moreau, P. Labarre, 1985, European journal of drug metabolism and pharmacokinetics.

Determination of adiphenine, diphenylacetic acid and diethylamino-ethanol by high-performance liquid chromatography.

J. Madelmont, M. Moreau, P. Labarre, 1983, Journal of chromatography.

Radiosynthesis of no-carrier-added N-(4-dipropyl aminobutyl)-4-[125I]-iodobenzamide, a promising tracer for the detection of melanoma

J. Papon, J. Madelmont, M. Moreau, 1998 .